MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines
about
Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assaysViability assays for cells in culture.The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats.Interference of Phenylethanoid Glycosides from Cistanche tubulosa with the MTT Assay.pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.HTS-FTIR spectroscopy allows the classification of polyphenols according to their differential effects on the MDA-MB-231 breast cancer cell line.Cellular Response to Linear and Branched Poly(acrylic acid).The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.Dietary phenolic acids act as effective antioxidants in membrane models and in cultured cells, exhibiting proapoptotic effects in leukaemia cellsCritical appraisal of the MTT assay in the presence of rottlerin and uncouplers.In vitro anticancer properties of selected Eucalyptus species.Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles In Vitro via Plate-Based, Flow Cytometry, and Coulter Counter Assays
P2860
Q28485861-DBB70E6A-1368-451D-B841-222B92D00174Q28488243-B70AE733-F961-401A-8A6B-4C7EECE60E32Q33872458-62D4AC39-040C-4A16-B27B-D83102353E7BQ33881060-A7A7C9BC-3A9A-4358-B068-F45E5BE9FF4CQ34334372-5B9ED4C2-454C-4A84-8D85-D112DCD4FE2FQ35157729-8B192B22-781A-4B00-9812-A991B9275FA7Q35624246-141A50C5-8423-4033-8012-B63627DEF6F4Q36367986-B73F6C45-C14A-49A0-89E7-5B235D14396AQ38727314-52D823A9-5FB3-476A-809B-B5B62FF70C16Q38844974-AE051BC5-354D-403D-B692-23AFA229B678Q38901500-0B9AD91A-34B9-45F8-ADDB-8CD158DE5B3AQ39315093-0F623955-DAE1-4A27-A99C-FF6B4230181FQ42255764-C09F7C86-6C43-422F-945A-9034C323D51DQ46375260-FEFC5B05-41E3-4232-B116-0715791EBE94Q58690459-195F9ED3-7809-462D-823B-1F5086C37742
P2860
MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MTT assays cannot be utilized ...... lity of solid tumor cell lines
@en
MTT assays cannot be utilized ...... ity of solid tumor cell lines.
@nl
type
label
MTT assays cannot be utilized ...... lity of solid tumor cell lines
@en
MTT assays cannot be utilized ...... ity of solid tumor cell lines.
@nl
prefLabel
MTT assays cannot be utilized ...... lity of solid tumor cell lines
@en
MTT assays cannot be utilized ...... ity of solid tumor cell lines.
@nl
P2860
P1476
MTT assays cannot be utilized ...... lity of solid tumor cell lines
@en
P2093
Jonathan T Sims
Rina Plattner
P2860
P2888
P304
P356
10.1007/S00280-009-1004-Y
P577
2009-04-26T00:00:00Z